Adam Koppel Insider Profile

11 Followers
Adam Koppel, EVP, Strategy and Bus. Dev at Biogen, holds 0.00 shares in Cerevel Therapeutics Holdings (Ticker: CERE), holds 4.03M shares in Solid Biosciences (Ticker: SLDB), holds 487.50K shares in BCLS Acquisition (Ticker: BLSA).
tipranks
Adam Koppel

Adam Koppel
Biogen (BIIB)
EVP, Strategy and Bus. Dev

Ranked #2,827 out of 98,834 Corporate Insiders

Profitable Transactions

80%
4 out of 5 Profitable Transactions

Average Return

+95.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$112M
73.80%
25.68%
0.52%
0.00%
0.00% Others
A breakdown of Adam Koppel's holdings

Insider Roles

PTC Therapeutics
(PTCT)
Director
Solid Biosciences
(SLDB)
Director, Ten Percent Owner
Biogen
(BIIB)
EVP, Strategy and Bus. Dev
Foghorn Therapeutics
(FHTX)
Director
+1 other positions
Roles that Adam Koppel holds in companies

Most Profitable Insider Trade

Stock:
Cerevel Therapeutics Holdings
(CERE)
Rating:Informative Buy
Date:Oct 29, 2020 - Oct 29, 2021
Return:+306.50%
The most profitable trade made by Adam Koppel

Adam Koppel's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Biogen
Jun 07, 2016
EVP, Strategy and Bus. Dev
Uninformative Sell
160.95K
$584.27K
DRNA
Dicerna Pharma
Dec 06, 2019
Informative Sell
37.02M
$117.85M
Solid Biosciences
Jan 12, 2024
Director, Ten Percent Owner
Uninformative Buy
5.00M
$28.81M
APTX
Aptinyx
Jan 16, 2020
Informative Buy
10.00M
$533.61K
BLSA
BCLS Acquisition
Oct 26, 2020
Uninformative Buy
4.88M
$4.89M
CERE
Cerevel Therapeutics Holdings
Aug 05, 2024
Uninformative Sell
$0.00
Foghorn Therapeutics
Director
PTC Therapeutics
Jun 27, 2013
Director
Uninformative Buy
$82.79M
Trevena
Director
$0.00
List of latest transactions for each holding click on a transaction to see Adam Koppel's performance on stock

Adam Koppel insider profile FAQ

What is the percentage of profitable transactions made by Adam Koppel?
The percentage of profitable transactions made by Adam Koppel is 80%.
    What is the average return per transaction made by Adam Koppel?
    The average return per transaction made by Adam Koppel is 95.30%.
      What stocks does Adam Koppel hold?
      Adam Koppel holds: BIIB, DRNA, SLDB, APTX, BLSA, CERE, FHTX, PTCT, TRVN stocks.
        What was Adam Koppel’s latest transaction?
        Adam Koppel latest transaction was an Uninformative Sell of ―.
          What was Adam Koppel's most profitable transaction?
          Adam Koppel’s most profitable transaction was an Informative Buy of CERE stock on October 29, 2020. The return on the trade was 306.50%.
            What is Adam Koppel's role in Biogen?
            Adam Koppel's role in Biogen is EVP, Strategy and Bus. Dev.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.